BioSpace News Archive

Antibe Therapeutics Inc. (TSXV: ATE, OTCQB: ATBPF) will host a conference call Thursday, June 4 at 10:00 am ET to discuss the recent positive results of the Phase 2B dose-ranging, efficacy study for ATB-346. Management will provide a brief summary of the results followed by a Q&A session for analysts.

Perrigo Company plc (NYSE; TASE: PRGO) today announced that President and CEO Murray S. Kessler will present further details on the Company’s consumer growth strategy along with a general update on the business at the 20th Annual Oppenheimer Consumer Growth and E-Commerce Virtual Conference at 2:00 PM EDT

Treadwell Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its third therapeutic candidate, CFI-402411, an oral, first-in-class inhibitor of hematopoietic progenitor kinase 1 (HPK1) in patients with solid tumors as a monotherapy or in combination with PD1 pathway blockade.

Rising number of people suffering from sleep and psychiatric disorders has compelled medical practitioners to check their vital body stats through ECG and EEG tests. The demand for ECG and EEG testing is progressively rising among patients suffering from insomnia or hyper-anxiety.

According to the recently-published report by Persistence Market Research, the global market for gene expression analysis will reflect a steady growth during the forecast period, 2017-2022. By the end of 2022, the global gene expression analysis market is predicted to surpass US$ 4,500 Mn valuation, reflecting a robust CAGR in terms of revenues.

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™ technology, announces its unaudited financial results for the second quarter of 2020.

With a growing load on the healthcare sector and consequently on the healthcare practitioners, the hospitals are looking for ways constantly to improve the working conditions of the doctors, nurses and other treatment staff. Hence, in order to avoid problems like back pain in doctors and nurses, ergonomically designed patient examination tables are used that are safe, flexible and reliable.

Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease, a new pilot study shows.

A new blood test can predict how well men with advanced prostate cancer will respond to treatment and could replace some of the existing methods used to characterise and track the disease.

Persistence Market Research delivers key insights and presents a revised forecast of the global fall detection system market for an eight year period from 2017 to 2025 in a report titled “Fall Detection System Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025).”